{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:00:30Z","timestamp":1778313630248,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.trim.2021.101378","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T16:22:52Z","timestamp":1613924572000},"page":"101378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["First report of liver transplantation in Blau syndrome: The challenges faced in this rare granulomatous liver disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Ricky","family":"Sinharay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorc\u00e1n","family":"McKeown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.H.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.trim.2021.101378_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9343(85)90286-4","article-title":"Familial granulomatous synovitis, uveitis, and cranial neuropathies","volume":"78","author":"Jabs","year":"1985","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.trim.2021.101378_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","article-title":"Familial granulomatous arthritis, iritis, and rash","volume":"107","author":"Blau","year":"1985","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.trim.2021.101378_bb0015","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Ros\u00e9","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.trim.2021.101378_bb0020","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1007\/s10620-019-05682-8","article-title":"An original description of granulomatous liver cirrhosis in Blau syndrome","volume":"64","author":"Cropley","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.trim.2021.101378_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2017.08.017","article-title":"Blau syndrome\u2013associated uveitis: preliminary results from an international prospective interventional case series","volume":"187","author":"Sarens","year":"2018","journal-title":"Am J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.trim.2021.101378_bb0035","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/ar4533","article-title":"Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome","volume":"16","author":"Ikeda","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.trim.2021.101378_bb0040","first-page":"1","article-title":"A case of Blau syndrome","volume":"2014","author":"Chauhan","year":"2014","journal-title":"Case Rep Rheumatol."},{"issue":"2","key":"10.1016\/j.trim.2021.101378_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.24222","article-title":"The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/00015555-2485","article-title":"Diagnosis and treatment of Blau syndrome\/early-onset sarcoidosis, an autoinflammatory granulomatous disease, in an infant","volume":"97","author":"Arvesen","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10792-015-0135-x","article-title":"Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis","volume":"36","author":"Achille","year":"2016","journal-title":"Int. Ophthalmol."},{"issue":"4","key":"10.1016\/j.trim.2021.101378_bb0060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3899\/jrheum.160672","article-title":"Tumor necrosis factor inhibitors provide Longterm clinical benefits in pediatric and young adult patients with Blau syndrome","volume":"44","author":"Nagakura","year":"2017","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12969-017-0188-7","article-title":"Co-existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report","volume":"15","author":"Dziedzic","year":"2017","journal-title":"Pediatr. Rheumatol."},{"issue":"5","key":"10.1016\/j.trim.2021.101378_bb0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.semarthrit.2017.09.010","article-title":"Blau syndrome with good reponses to tocilizumab: a case report and focused literature review","volume":"47","author":"Lu","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.trim.2021.101378_bb0075","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4103\/ijo.IJO_629_18","article-title":"Uveitis in sporadic Blau syndrome: long-term follow-up of a refractory case treated successfully with adalimumab","volume":"66","author":"Naik","year":"2018","journal-title":"Indian J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00124743-200002000-00005","article-title":"Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an african-american family","volume":"6","author":"Cuesta","year":"2000","journal-title":"J. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","article-title":"Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism","volume":"62","author":"Yasui","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.trim.2021.101378_bb0090","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.22122","article-title":"Pediatric granulomatous arthritis: an international registry","volume":"54","author":"Ros\u00e9","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"42","key":"10.1016\/j.trim.2021.101378_bb0095","first-page":"3631","article-title":"Blau syndrome in monozygotic twins","volume":"168","author":"Milman","year":"2006","journal-title":"Ugeskr. Laeger"},{"issue":"12","key":"10.1016\/j.trim.2021.101378_bb0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","article-title":"Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation","volume":"114","author":"Milman","year":"2006","journal-title":"APMIS."},{"issue":"4","key":"10.1016\/j.trim.2021.101378_bb0105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.22509","article-title":"Interstitial pneumonitis in Blau syndrome with documented mutation inCARD15","volume":"56","author":"Becker","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.trim.2021.101378_bb0110","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Ar\u00f3stegui","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.trim.2021.101378_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D31GZ33233","article-title":"Two pediatric cases of Blau syndrome","volume":"15","author":"Glass","year":"2009","journal-title":"Dermatol Online J."},{"issue":"4","key":"10.1016\/j.trim.2021.101378_bb0120","first-page":"586","article-title":"Sarcoidosis in childhood: report of three cases","volume":"28","author":"Cavalcanti","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.trim.2021.101378_bb0125","first-page":"1","article-title":"Etanercept-induced myelopathy in a pediatric case of Blau syndrome","volume":"2011","author":"Caracseghi","year":"2011","journal-title":"Case Rep Rheumatol."},{"issue":"2","key":"10.1016\/j.trim.2021.101378_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaapos.2011.02.004","article-title":"Uveitis in Blau syndrome from a de novo mutation of the NOD2\/CARD15 gene","volume":"15","author":"Raiji","year":"2011","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus."},{"issue":"5","key":"10.1016\/j.trim.2021.101378_bb0135","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/keq431","article-title":"Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNF\u03b1 monoclonal antibodies","volume":"50","author":"Sharma","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.trim.2021.101378_bb0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.37776","article-title":"Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis","volume":"65","author":"Simonini","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.trim.2021.101378_bb0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","article-title":"Adalimumab therapy for refractory childhood uveitis","volume":"17","author":"Bravo-Ljubetic","year":"2013","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus."},{"issue":"2","key":"10.1016\/j.trim.2021.101378_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10067-014-2493-6","article-title":"Early-onset sarcoidosis caused by a rare CARD15\/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature","volume":"34","author":"La Torre","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.trim.2021.101378_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006177","article-title":"Nod2: The intestinal gate keeper","volume":"13","author":"Al Nabhani","year":"2017","journal-title":"PLOS Pathog"},{"issue":"12","key":"10.1016\/j.trim.2021.101378_bb0160","doi-asserted-by":"crossref","first-page":"140178","DOI":"10.1098\/rsob.140178","article-title":"Insights into the molecular basis of the NOD2 signalling pathway","volume":"4","author":"Boyle","year":"2014","journal-title":"Open Biol."},{"issue":"18","key":"10.1016\/j.trim.2021.101378_bb0165","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.febslet.2014.07.029","article-title":"Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators","volume":"588","author":"Parkhouse","year":"2014","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.trim.2021.101378_bb0170","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0530276100","article-title":"Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases","volume":"100","author":"Chamaillard","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.trim.2021.101378_bb0175","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","article-title":"Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome","volume":"105","author":"Kanazawa","year":"2005","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.trim.2021.101378_bb0180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.24134","article-title":"Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis","volume":"60","author":"Okafuji","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.trim.2021.101378_bb0185","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jaci.2012.02.004","article-title":"Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2\u2013related disorders Blau syndrome and Crohn disease","volume":"129","author":"Janssen","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2021.101378_bb0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00296-006-0250-0","article-title":"Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2","volume":"27","author":"Kim","year":"2007","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.trim.2021.101378_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4081\/reumatismo.2014.772","article-title":"Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome","volume":"66","author":"Galozzi","year":"2015","journal-title":"Reumatismo."},{"issue":"8","key":"10.1016\/j.trim.2021.101378_bb0200","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/art.24691","article-title":"Interleukin-1beta suppression in Blau syndrome: comment on the article by Martin et al","volume":"60","author":"Masumoto","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.trim.2021.101378_bb0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-009-1342-4","article-title":"Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome","volume":"30","author":"Son","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.trim.2021.101378_bb0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1753425917727063","article-title":"A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: phenotype and function","volume":"23","author":"Ong","year":"2017","journal-title":"Innate Immun."},{"key":"10.1016\/j.trim.2021.101378_bb0215","article-title":"A young female with early onset arthritis, uveitis, hepatic, and renal granulomas: a clinical tryst with Blau syndrome over 20 years and case-based review","author":"Jindal","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.trim.2021.101378_bb0220","series-title":"Liver Involvement in Familial Granulomatous Arthritis (Blau syndrome)","article-title":"RCL involvement in familial granulomatous arthritis (Blau syndrome). JR 1996 F-9. P 8882056","author":"Saini","year":"1996"},{"key":"10.1016\/j.trim.2021.101378_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217320","article-title":"Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation","author":"Matsuda","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"S1","key":"10.1016\/j.trim.2021.101378_bb0230","doi-asserted-by":"crossref","first-page":"P5","DOI":"10.1186\/1546-0096-13-S1-P5","article-title":"Monogenetic autoinflammatory syndromes and nephrology - therapy is usefull even in advanced kidney failure","volume":"13","author":"Hohenstein-Scheibenecker","year":"2015","journal-title":"Pediatr. Rheumatol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:00:14Z","timestamp":1760810414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327421000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"alternative-id":["S0966327421000186"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2021.101378","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First report of liver transplantation in Blau syndrome: The challenges faced in this rare granulomatous liver disease","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2021.101378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101378"}}